Room 1,2,4,5¿¡¼´Â ÀϹݿ¬Á¦ ¹ßÇ¥°¡ ÁøÇàµË´Ï´Ù.
Oral ¹Ù·Î°¡±â >
Room 3 - Joint Session: ´ëÇѸðüžÆÀÇÇÐȸ
|
Proper management of labor and delivery |
³ëÁ¤·¡(¼º±Õ°üÀÇ´ë), ±è¿µÁÖ(ÀÌÈÀÇ´ë) |
08:00-08:20 |
Decision-making for emergency cesarean section |
¿À¹ÎÁ¤(°í·ÁÀÇ´ë) |
08:20-08:40 |
Diagnostic criteria for abnormal labor: ACOG guideline 2016 |
¼º¿øÁØ(°æºÏÀÇ´ë) |
08:40-09:00 |
Management of abnormal labors |
°íÇö¼±(°¡Å縯ÀÇ´ë) |
09:00-09:20 |
Review of 3-tier fetal heart rate interpretation system |
¼³ÇöÁÖ(°æÈñÀÇ´ë) |
09:20-09:40 |
Intrapartum management of category II FHB tracing |
ÀÌÁØÈ£(¿¬¼¼ÀÇ´ë) |
09:40-10:00 |
Neonatal outcomes in category II and III FHB tracing |
Á¤ÁøÈÆ(¿ï»êÀÇ´ë) |
Room 1~5
10:20-11:00 |
°³È¸½Ä & ½Ã»ó½Ä |
±è¿ëºÀ(´ëÇÑ»êºÎÀΰúÇÐȸ ȸÀå) ÀÌÇÊ·®(´ëÇÑ»êºÎÀΰúÇÐȸ ÀÌ»çÀå) |
|
¿ì¼öÇмú³í¹®¹ßÇ¥ ENG |
¹ÚÁß½Å(¼¿ïÀÇ´ë), ±è¼ºÈÆ(¿¬¼¼ÀÇ´ë) |
11:00-11:10 |
Pre-pregnancy risk factors for severe hyperemesis gravidarum: Korean population based cohort study |
±èÈ£¿¬(°í·ÁÀÇ´ë) |
11:10-11:20 |
E2F8 Induces Cell Proliferation and Invasion through the Epithelial-Mesenchymal Transition and Notch Signaling Pathways in Ovarian Cancer |
¾î°æÁø(¿¬¼¼ÀÇ´ë) |
|
Plenary I ENG |
ÀÌÅÃÈÄ(°æºÏÀÇ´ë), È«¼øö(°í·ÁÀÇ´ë) |
11:20-11:40 |
Endometrial decidualization: preventing adverse outcomes before the pregnancy begins |
Errol Norwitz(Tufts Univ, USA) |
11:40-12:00 |
Epigenetic dysregulation in endometriosis-related infertility |
Jae-wook Jeong(Michigan State Univ, USA) |
|
Luncheon Symposium |
|
12:00-13:00 |
HPV ¹é½Å, Á߳⠿©¼º°ú ³²¼º Á¢Á¾ÀÇ Çʿ伺 |
ÁÖ¿ø´ö(Â÷ÀÇ°úÇдë) |
Room 3 - Joint Session: ´ëÇѺÎÀÎÁ¾¾çÇÐȸ
13:00-13:05 |
Opening Remark |
±è¿µÅ (´ëÇѺÎÀÎÁ¾¾çÇÐȸ ȸÀå) |
Session I |
Shooting stars in surgical field ENG |
ÁÂÀå: ±èÀç¿ø (¼¿ïÀÇ´ë) |
13:05-13:25 |
Laparoscopic surgery for isolated or localized tumors in gynecologic cancer |
Valerio Gallotta (IRCCS Fondazione Policlinico Universitario A. Gemelli, Italy) |
13:25-13:30 |
Designated discussion |
ÀÌ»êÈñ (¿¬¼¼¿øÁÖÀÇ´ë) |
13:30-13:50 |
HIPEC in recurrent ovarian cancer |
Oliver Zivanovic (Memorial Sloan Kettering Cancer Center, USA) |
13:50-13:55 |
Designated discussion |
Àå¼®ÁØ (¾ÆÁÖÀÇ´ë) |
Session II |
Future direction |
ÁÂÀå: ÀÌÀç°ü (°í·ÁÀÇ´ë) |
13:55-14:10 |
Liquid biopsy |
ÀÌ¿ìâ (¿ï»êÀÇ´ë Áø´Ü°Ë»çÀÇÇаú) |
14:10-14:25 |
CAR T-cell therapy |
°í¿µÀÏ (¼¿ïÀÇ´ë Ç÷¾×Á¾¾ç³»°ú) |
14:25-14:40 |
Radiomics |
¹Ú½ÅÇü (°æºÏÀÇ´ë ¹æ»ç¼±Á¾¾çÇаú) |
Session ¥² |
Special lecture |
|
14:40-15:00 |
Prevention of febrile neutropenia: prophylactic use of PEG G-CSF in gynecologic malignancies |
À̽ÅÈ (¿ï»êÀÇ´ë) |
15:00-15:40 |
Coffee break |
|
Room 1~5
|
Position Statement |
±èÀç¿ø(¼¿ïÀÇ´ë) |
15:40-15:50 |
Patient blood management (PBM) in obstetrics |
ÃÖ¼¼°æ(°¡Å縯ÀÇ´ë) |
15:50-16:00 |
Patient blood management (PBM) in gynecologic surgery for benign tumor |
ÀÌ»ç¶ó(¿ï»êÀÇ´ë) |
16:00-16:10 |
Çö¸íÇÑ ¼±ÅÃ(Choosing Wisely) |
±è¹Ì¼±(Â÷ÀÇ°úÇдë) |
|
Special Session II |
Çã¼ö¿µ(°¡Å縯ÀÇ´ë), ¹Ú¹ÌÇý(ÀÌÈÀÇ´ë) |
16:10-16:30 |
Tdap ¹é½Å ÃֽŠ¾÷µ¥ÀÌÆ® |
Á¶±ÝÁØ(°í·ÁÀÇ´ë) |
16:30-16:50 |
Optimizing Treatment for CIPN Patients |
À±ÁÖÈñ(°¡Å縯ÀÇ´ë) |
|
Plenary II ENG |
Ȳ°æÁÖ(¾ÆÁÖÀÇ´ë), ÀÌÁ¤¿ø(¼º±Õ°üÀÇ´ë) |
16:50-17:10 |
Environmental endocrine disrupters |
Hugh Taylor(Yale School of Medicine, USA) |
17:10-17:30 |
Surgical advances in the treatment of Gynecologic cancers |
Ernest Han(City of Hope, USA) |
17:30-17:50 |
½Ã»ó½Ä |
|